United States - English - NLM (National Library of Medicine)

hikma pharmaceuticals usa inc. - clonidine hydrochloride (unii: w76i6xxf06) (clonidine - unii:mn3l5rmn02) - clonidine hydrochloride 100 ug in 1 ml - clonidine hydrochloride injection, usp is indicated in combination with opiates for the treatment of severe pain in cancer patients that is not adequately relieved by opioid analgesics alone. epidural clonidine is more likely to be effective in patients with neuropathic pain than somatic or visceral pain (see clinical pharmacology: clinical trials). the safety of this drug product has only been established in a highly selected group of cancer patients, and only after an adequate trial of opioid analgesia. other use is of unproven safety and is not recommended. in a rare patient, the potential benefits may outweigh the known risks (see warnings). clonidine hydrochloride injection is contraindicated in patients with a history of sensitization or allergic reactions to clonidine. epidural administration is contraindicated in the presence of an injection site infection, in patients on anticoagulant therapy, and in those with a bleeding diathesis. administration of clonidine hydrochloride injection above the c4 der

New Zealand - English - Medsafe (Medicines Safety Authority)

viatris limited - clonidine 2.52mg equivalent to 0.1 mg/24hr - transdermal patch - 0.1 mg/24h - active: clonidine 2.52mg equivalent to 0.1 mg/24hr excipient: adhesive 8400e/000 colloidal silicon dioxide durotak 87-613a ethylenevinylacetate copolymer heptane light liquid paraffin no tox ink brown- fgn4476 - clonidine transdermal system usp is indicated for the treatment of mild to moderate hypertension. it can be used as monotherapy or concomitantly with other antihypertensive agents if required to enhance hypotensive effect.

New Zealand - English - Medsafe (Medicines Safety Authority)

viatris limited - clonidine 5.04mg equivalent to 0.2 mg/24hr - transdermal patch - 0.2 mg/24h - active: clonidine 5.04mg equivalent to 0.2 mg/24hr excipient: adhesive 8400e/000 colloidal silicon dioxide durotak 87-613a ethylenevinylacetate copolymer heptane light liquid paraffin no tox ink brown- fgn4476 - clonidine transdermal system usp is indicated for the treatment of mild to moderate hypertension. it can be used as monotherapy or concomitantly with other antihypertensive agents if required to enhance hypotensive effect.

New Zealand - English - Medsafe (Medicines Safety Authority)

viatris limited - clonidine 7.56mg equivalent to 0.3mg/24hr - transdermal patch - 0.3 mg/24h - active: clonidine 7.56mg equivalent to 0.3mg/24hr excipient: adhesive 8400e/000 colloidal silicon dioxide durotak 87-613a ethylenevinylacetate copolymer heptane light liquid paraffin no tox ink brown- fgn4476 - clonidine transdermal system usp is indicated for the treatment of mild to moderate hypertension. it can be used as monotherapy or concomitantly with other antihypertensive agents if required to enhance hypotensive effect.

United States - English - NLM (National Library of Medicine)

mckesson corporation dba sky packaging - clonidine hydrochloride (unii: w76i6xxf06) (clonidine - unii:mn3l5rmn02) - clonidine hydrochloride 0.1 mg - clonidine hydrochloride tablets, usp are indicated in the treatment of hypertension. clonidine hydrochloride tablets may be employed alone or concomitantly with other antihypertensive agents. clonidine hydrochloride tablets should not be used in patients with known hypersensitivity to clonidine (see precautions ).

United States - English - NLM (National Library of Medicine)

a-s medication solutions - clonidine hydrochloride (unii: w76i6xxf06) (clonidine - unii:mn3l5rmn02) - clonidine hydrochloride 0.1 mg - clonidine hydrochloride tablets, usp are indicated in the treatment of hypertension. clonidine hydrochloride tablets, usp may be employed alone or concomitantly with other antihypertensive agents. clonidine hydrochloride tablets should not be used in patients with known hypersensitivity to clonidine (see precautions ).

United States - English - NLM (National Library of Medicine)

jubilant cadista pharmaceuticals inc. - clonidine hydrochloride (unii: w76i6xxf06) (clonidine - unii:mn3l5rmn02) - clonidine hydrochloride extended-release tablets are indicated for the treatment of attention deficit hyperactivity disorder (adhd) as monotherapy and as adjunctive therapy to stimulant medications [see clinical studies (14)]. clonidine hydrochloride extended-release tablets are contraindicated in patients with a history of a hypersensitivity reaction to clonidine. reactions have included generalized rash, urticaria, and angioedema [see adverse reactions (6)]. pregnancy category c :   risk summary there are no adequate or well-controlled studies with clonidine hydrochloride in pregnant women. in animal embryofetal studies, increased resorptions were seen in rats and mice administered oral clonidine hydrochloride from implantation through organogenesis at 10 and 5 times, respectively, the maximum recommended human dose (mrhd). no embryotoxic or teratogenic effects were seen in rabbits administered oral clonidine hydrochloride during organogenesis at doses up to 3 times the mrhd. clonidine hydr

Australia - English - Department of Health (Therapeutic Goods Administration)

medsurge pharma pty ltd - clonidine hydrochloride, quantity: 150 microgram/ml - injection, solution - excipient ingredients: sodium chloride; hydrochloric acid; water for injections - clonidine hci injection medsurge is indicated for acute hypertensive crisis and as an alternative to oral therapy where the oral route of administration is inappropriate.

New Zealand - English - Medsafe (Medicines Safety Authority)

medsurge pharma limited - clonidine hydrochloride 150 µg/ml - solution for injection - 150 mcg/ml - active: clonidine hydrochloride 150 µg/ml excipient: hydrochloric acid sodium chloride water for injection - for the treatment of hypertensive crises, slow parenteral administration is especially suitable due to the rapid onset of action.

Malta - English - Medicines Authority

syri pharma limited floor 0 1 wml, 1 windmill lane dublin 2, d02 f206, ireland - clonidine hydrochloride - oral solution - clonidine hydrochloride 50 µg/5ml - analgesics